Literature DB >> 3337191

Prostaglandin F2 alpha-1-isopropylester lowers intraocular pressure without decreasing aqueous humor flow.

J R Kerstetter1, R F Brubaker, S E Wilson, L J Kullerstrand.   

Abstract

Using fluorophotometry, we performed a randomized, dose-response study of the effects of a prostaglandin derivative on aqueous humor flow. Prostaglandin F2 alpha 1-isopropylester, 0.224 micrograms, 0.448 micrograms, and 1.120 micrograms, in saline with polysorbate 80 was instilled into one eye of 20 subjects in three separate dose studies. Polysorbate 80 in saline was instilled in the fellow eye as a control. The drug had no measurable effect on aqueous humor flow or corneal endothelial permeability. Intraocular pressure measured eight hours after administration of the highest dose, 1.120 micrograms, was 20% lower in the treated eye as compared to the fellow eye (P less than .001).

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3337191     DOI: 10.1016/0002-9394(88)90117-1

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  20 in total

1.  Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure.

Authors:  M Kimal Arici; A Topalkara; C Güler
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

2.  Correlation between individual differences in intraocular pressure reduction and outflow facility due to latanoprost in normal-tension glaucoma patients.

Authors:  Nobuhiko Kondo; Akira Sawada; Tetsuya Yamamoto; Toru Taniguchi
Journal:  Jpn J Ophthalmol       Date:  2006 Jan-Feb       Impact factor: 2.447

3.  The role of prostaglandins in the para-aminoclonidine-induced reduction of intraocular pressure.

Authors:  R F Wang; C B Camras; S M Podos; K W Lee; K C Bhuyan; D K Bhuyan
Journal:  Trans Am Ophthalmol Soc       Date:  1989

Review 4.  Latanoprost. A review of its pharmacological properties, clinical efficacy and tolerability in the management of primary open-angle glaucoma and ocular hypertension.

Authors:  S S Patel; C M Spencer
Journal:  Drugs Aging       Date:  1996-11       Impact factor: 3.923

5.  Prostaglandin F2 alpha-isopropylester eye drops: effects in normal human eyes.

Authors:  J Villumsen; A Alm
Journal:  Br J Ophthalmol       Date:  1989-06       Impact factor: 4.638

Review 6.  Effects of prostaglandin analogues on aqueous humor outflow pathways.

Authors:  Nelson S Winkler; Michael P Fautsch
Journal:  J Ocul Pharmacol Ther       Date:  2013-12-20       Impact factor: 2.671

7.  Comparison of 1-year surgical outcomes of combined cataract surgery and gonioscopy-assisted transluminal trabeculotomy (GATT) versus cataract surgery and iStent Inject.

Authors:  Hisham Hamze; Abhijit Anand Mohite; Pravin Pandey; Velota C T Sung; Imran Masood
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-05-20       Impact factor: 3.117

8.  Trabecular aspiration: a new surgical approach to improve trabecular facility in pseudoexfoliation glaucoma.

Authors:  P C Jacobi; G K Krieglstein
Journal:  Int Ophthalmol       Date:  1994       Impact factor: 2.031

Review 9.  Prostaglandin analogues in the treatment of glaucoma.

Authors:  C Lindén; A Alm
Journal:  Drugs Aging       Date:  1999-05       Impact factor: 3.923

10.  Localisation of prostaglandin F2 alpha and E2 binding sites in the human eye.

Authors:  T Matsuo; M S Cynader
Journal:  Br J Ophthalmol       Date:  1992-04       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.